16 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
multiple sources, including the Company’s personnel who oversee the pre-clinical and clinical trial activities, information from service providers
20-F/A
epczhnt2e50pac
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
yx52 x8iip
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
nlye9g0z
9 Oct 15
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate Development Officer
12:00am
20-F
yn9cb1v6t28zf j2
31 Mar 15
Annual report (foreign)
12:00am
424B4
fxby1nx
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
u38pravm
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next